WO2008075878A1 - Composition alimentaire à utiliser en tant que substitut aux antibiotiques, à base d'inuline extraite d'artichaut de jérusalem - Google Patents
Composition alimentaire à utiliser en tant que substitut aux antibiotiques, à base d'inuline extraite d'artichaut de jérusalem Download PDFInfo
- Publication number
- WO2008075878A1 WO2008075878A1 PCT/KR2007/006634 KR2007006634W WO2008075878A1 WO 2008075878 A1 WO2008075878 A1 WO 2008075878A1 KR 2007006634 W KR2007006634 W KR 2007006634W WO 2008075878 A1 WO2008075878 A1 WO 2008075878A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inulin
- feed
- inuloprebiotics
- jerusalem artichoke
- feed composition
- Prior art date
Links
- 229920001202 Inulin Polymers 0.000 title claims abstract description 39
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 title claims abstract description 39
- 229940029339 inulin Drugs 0.000 title claims abstract description 39
- 240000008892 Helianthus tuberosus Species 0.000 title claims abstract description 16
- 235000003230 Helianthus tuberosus Nutrition 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 230000003115 biocidal effect Effects 0.000 title description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 9
- 244000144972 livestock Species 0.000 claims description 10
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 235000019738 Limestone Nutrition 0.000 claims description 2
- 235000019752 Wheat Middilings Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 239000006028 limestone Substances 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract description 20
- 229940088710 antibiotic agent Drugs 0.000 abstract description 20
- 239000003674 animal food additive Substances 0.000 abstract description 10
- 241000186016 Bifidobacterium bifidum Species 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 235000013406 prebiotics Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 5
- 210000004534 cecum Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- 241000193468 Clostridium perfringens Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000009629 microbiological culture Methods 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 2
- 230000001847 bifidogenic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a feed additive for use as a substitute for antibiotics, which contains inulin extracted from Jerusalem artichoke, and more particularly, to feed composition as a substitute for antibiotics, which contains an inuloprebiotics, which is prepared by mixing inulin, extracted from Jerusalem artichoke, with an excipient.
- Antibiotics have been primarily used for the prevention and treatment of diseases, but the use of antibiotics as antibacterial growth promoters in feed is being gradually prohibited. Thus, there is a need to develop novel materials, which are natural materials and, at the same time, have the effect of killing harmful bacteria, like antibiotics.
- inulin which is composed of polysaccharides and accounts for more than 50% of Jerusalem artichoke.
- Said inulin are fructose polymers linked by /3-2,1 bonds with the chemical structure of a non-reducing terminal ⁇ -2,1 glucosidic bond.
- inulin is not degraded by gastric juice and digestive enzymes of human beings and livestock, more than about 80% of inulin reaches the large intestine and is fermented by intestinal microorganisms, and it has a bifidogenic effect of selectively stimulating the growth of bifidobacteria, known as beneficial intestinal microorganisms, and at the same time, inhibiting the i growth of harmful microorganisms.
- bifidobacteria known as beneficial intestinal microorganisms
- inulin has been reported to have the effects of alleviating obesity, promoting bowel movement, reducing blood insulin and neutral lipid levels and inhibiting the development of colon cancer.
- inulin consisting of 2-
- FOS fructo-oligosaccharide
- Prebiotics are novel materials receiving attention as feed additives and functional food materials capable of substituting for probiotics and antibiotics.
- the term "prebiotics” refers to non-degradable dietary indegredients, which are not degraded in the stomach and the small intestine and move into the large intestine to selectively stimulate the growth of microorganisms such as bifidobacterium bifidum in the colon or stimulate a limited number of microorganisms, thus providing a beneficial effect to human beings and livestock.
- Such prebiotics microbiologically produce nutrients, such as antibiotics, vitamins and growth promoting factors, in the large intestine, to improve gastrointestinal functions, increase the bioavailability of minerals and the amount of feces, prevent diarrhea, and enhance immune functions, thus promoting the growth of animals (Cummings, et ah, Brit. J. Nutr., 87:S145, 2002; Patterson et al., Poult. ScL, 82:627, 2003; George et al., Brit. Med. J., 318:999, 1999).
- the present inventors have made many efforts to develop a feed additive for use as a substitute for antibiotics and, as a result, have prepared an inuloprebiotics-containing feed additive as a substitute for antibiotics using inulin extracted from Jerusalem artichoke, and have found that, when the feed additive is fed to livestock, it has a bifidogenic effect of inhibiting the growth of harmful microorganisms in the intestines, thereby completing the present invention.
- the present invention provides an antibiotic-free feed composition, which comprises an inuloprebiotics containing 100 parts by weight of an excipient selected from the group consisting of barley bran, wheat middling, limestone powder, and maize powder; and 0.05-10 parts by weight of inulin extracted from Jerusalem artichoke.
- the present invention provides a method for raising livestock, which comprises feeding said feed composition to livestock.
- FIG. 1 shows a comparison of the growth curves of Bifidobacterium bifidum in an inulin- containing medium and an inulin-free medium.
- FIG. 2 shows a comparison of the growth curves of Clostridium perfringens in an inulin-containing medium and an inulin-free medium.
- inuloprebiotics which is a feed additive for use as a substitute for antibiotics
- 0.05-10 parts by weight of inulin, extracted from Jerusalem artichoke was mixed with 100 parts by weight of barley bran which is an excipient.
- the prepared inuloprebiotics were added to feed in an amount of 0.1-0.5 parts by weight based on 100 parts by weight of the feed, thus preparing a feed composition. It was observed that, when the feed composition was fed to animals, it had the effect of substituting for antibiotics.
- Example 1 Inulin extraction
- Jerusalem artichoke was washed, crushed or cut thinly, and steamed in an autoclave for 30 minutes.
- the steamed Jerusalem artichoke was mixed with water (80 "C) at a ratio of 1 ::5 and, and the mixture was stirred for 20 minutes.
- the stirred mixture solution was filtered through cotton cloth, and the filtrate was centrifuged at 3,000 rpm. The precipitate was collected and dried, thus extracting inulin.
- Example 1 Using the inulin extracted in Example 1, the growth rates of Bifidobacterium bifidum, known as typical beneficial intestinal bacteria, and Clostridium perfringens, known as harmful bacteria, were measured in liquid media. For this purpose, in a microbial culture medium containing 0.5 wt% of said inulin, Bifidobacterium bifidum and Clostridium perfringens were incubated at 37 ° C for 48 hours. The growth rates of the microorganisms were measured by comparing the OD value of the bacteria, grown in an inulin-free liquid medium, with the OD value of the bacteria grown in the inulin-containing liquid medium.
- the case of using the microbial culture medium containing 0.5 wt% of inulin showed the effect of promoting the growth of Bifidobacterium bifidum after 15 hours from the start of the incubation, unlike the case of using the inulin-free culture medium.
- the case of using microbial culture medium containing 0.5 wt% of inulin showed the effect of inhibiting the growth of the Clostridium perfringens strain after 15 hours from the start of the incubation. This suggests that the Jerusalem artichoke- derived inulin had the "prebiotic" effect of promoting the growth of Bifidobacteria.
- Example 3 Optimum content of inulin in inuloprebiotics
- broilers Chicken hatchery, Korea
- 5 groups x 4 repeat pens (25 broilers/replication and fed with starter feed (Heungsung Feed Corp.,
- Example 1 The inulin obtained in Example 1 was added to 1 kg of barely bran in various amounts of 25 g, 50 g, 75 g and 100 g to prepare inuloprebiotics, 0.3 wt% of which were then added to compound feed (containing feed additives, including antibiotics, probiotics, enzymes, vitamins and minerals, at the highest levels), thus preparing test feed samples.
- compound feed containing feed additives, including antibiotics, probiotics, enzymes, vitamins and minerals, at the highest levels
- test feed containing feed additives, including antibiotics, probiotics, enzymes, vitamins and minerals, at the highest levels
- the group treated with the inuloprebiotics containing 50 g of inulin per kg of barley bran showed increases in body weight, feed efficiency and the number of Bifidobacterium bifidum bacteria, and showed a decrease in the number (CFU log 10/kg) of harmful E. coli bacteria in the cecum (p ⁇ 0.05).
- the number of microorganisms in the ceca of the groups treated with the inuloprebiotics containing inulin in amounts of 75 g and 100 g, respectively, did not show a difference from that of the group treated with the inuloprebiotics containing 50 g of inulin.
- Table 1 Change in growth rate (0-35 days) and number of cecal microorganisms of broilers at various levels of inuloprebiotics addition
- Inuloprebiotics inulin g/kg excipient
- Example 3 Based on the results of Example 3 above, an inuloprebiotics containing 1 kg of an excipient and 50 g of inulin was prepared. 500 broilers (Chicken hatchery, Korea) were divided into 5 groups x 4 repeat pens (25 broilers/replication) and fed with starter feed (Heungsung Feed Corp., Korea) for 3 days. Then, the above-prepared inuloprebiotics (50 g of inulin per kg of barley bran) was added to compound feed in amounts of 0.1 wt%, 0.2 wt% and 0.3 wt%, thus preparing test feed samples. The feed samples were compared with a control sample and a sample containing commercial antibiotics.
- 500 broilers Chicken hatchery, Korea
- starter feed Heungsung Feed Corp., Korea
- the animals were raised in an animal farm, Kangwon National University, to a market age of 35 days, while the growth rate thereof was examined, and the number of microorganisms in the cecal contents and the blood immunoglobulin (IgG) level of the animals were measured in the Lipid Medical Biotechnology Laboratory, College of Animal Life Science, Kangwon National University).
- IgG blood immunoglobulin
- the feed intake and the blood IgG level were not significantly different between all the test groups, and the weight, the feed efficiency, the number (CFU log 10/kg) of beneficial Bifidobacterium bifidum bacteria in the cecum, and the number (CFU log 10/kg) of harmful E. coli bacteria in the cecum, were not significantly different between the control group and the group treated with 0.1 wt% of the inuloprebiotics.
- Inuloprebiotics inulin g/kg excipient
- the present invention provides an antibiotic-free feed composition, which comprises an inuloprebiotics containing inulin extracted from Jerusalem artichoke.
- antibiotic-free meat can be produced by raising healthy livestock without using antibiotics.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
La présente invention concerne un additif alimentaire à utiliser en tant que substitut aux antibiotiques, qui contient de l'inuline extraite d'artichaut de Jérusalem. L'invention concerne plus particulièrement une composition alimentaire sans antibiotiques qui contient un inuloprébiotique préparé par mélange d'inuline extraite d'artichaut de Jérusalem à un excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2006-0132077 | 2006-12-21 | ||
KR20060132077 | 2006-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008075878A1 true WO2008075878A1 (fr) | 2008-06-26 |
Family
ID=39536459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/006634 WO2008075878A1 (fr) | 2006-12-21 | 2007-12-18 | Composition alimentaire à utiliser en tant que substitut aux antibiotiques, à base d'inuline extraite d'artichaut de jérusalem |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008075878A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010092661A1 (fr) | 2009-02-10 | 2010-08-19 | トヨタ自動車株式会社 | Mécanisme de transmission à variation continue et boîte de vitesses utilisant un mécanisme de transmission à variation continue |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0850569B1 (fr) * | 1996-12-24 | 2000-07-12 | Societe Des Produits Nestle S.A. | Produit céréalier gélatinisé contenant un ologisaccharide |
US20050281910A1 (en) * | 1999-09-22 | 2005-12-22 | Eduardo Schiffrin | Method for increasing pet activity |
-
2007
- 2007-12-18 WO PCT/KR2007/006634 patent/WO2008075878A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0850569B1 (fr) * | 1996-12-24 | 2000-07-12 | Societe Des Produits Nestle S.A. | Produit céréalier gélatinisé contenant un ologisaccharide |
US20050281910A1 (en) * | 1999-09-22 | 2005-12-22 | Eduardo Schiffrin | Method for increasing pet activity |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010092661A1 (fr) | 2009-02-10 | 2010-08-19 | トヨタ自動車株式会社 | Mécanisme de transmission à variation continue et boîte de vitesses utilisant un mécanisme de transmission à variation continue |
CN102216653A (zh) * | 2009-02-10 | 2011-10-12 | 丰田自动车株式会社 | 无级变速机构以及使用该无级变速机构的变速器 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lauzon et al. | Probiotics and prebiotics: concepts, definitions and history | |
Qiang et al. | Health benefit application of functional oligosaccharides | |
EP0901371B1 (fr) | Modification apportee a des populations microbiennes dans le tractus gastro-intestinal | |
Erik et al. | Development of antibiotic resistance and options to replace antimicrobials in animal diets | |
EP3476226B1 (fr) | Composition immunomodulatrice et promotrice de la croissance et du contrôle de la population de bactéries indésirables du microbiote intestinal | |
CN104349784A (zh) | 动物饲料组合物及使用其的方法 | |
CN102573798A (zh) | 改善胃肠健康的方法和组合物 | |
CN109315626A (zh) | 一种猫无谷粮及其制备方法 | |
Han et al. | Comparison of the effects of longer chain inulins with different degrees of polymerization on colonic fermentation in a mixed culture of swine fecal bacteria | |
CN116782771A (zh) | 用于支持患有胃肠病症的伴侣动物的组合物和相关方法 | |
Perdinan et al. | Body resistance and growth performance of broiler fed glucomannan extracted from Amorphophallus onchophyllus tuber | |
Kovitvadhi et al. | Effects of dietary supplementation with different levels and molecular weights of fungal β-glucan on performances, health and meat quality in broilers | |
CN101297679A (zh) | 一种提高畜禽免疫力的饲料添加剂及其制备方法 | |
CN111885922A (zh) | 饲料用添加剂及饲料 | |
JP5698427B2 (ja) | グルタミンを含む下痢止め組成物 | |
Akoy | The effects of probiotics, prebiotics and synbiotics on gut flora, immune function and blood characteristics of broilers | |
WO2008075878A1 (fr) | Composition alimentaire à utiliser en tant que substitut aux antibiotiques, à base d'inuline extraite d'artichaut de jérusalem | |
CN114344341B (zh) | 具有调节肠道作用的复合益生菌组合物及制备方法和应用 | |
JP5393450B2 (ja) | 腸管病原体に対する凝集剤として好適なトリ−およびテトラ−オリゴ糖 | |
WO2016136624A1 (fr) | Immunomodulateur et utilisation de ce dernier | |
AU2020102172A4 (en) | A Compound Fiber Additive for Improving Pork Quality and Its Preparation and Application | |
CN102669485B (zh) | 肉鸡专用型动物生命素及其制备方法 | |
CN114456969A (zh) | 一种用于减肥降血糖的益生菌制剂及其制备方法和应用 | |
BR102017010683B1 (pt) | composição imunomoduladora e promotora de crescimento e de controle da população de bactérias indesejáveis da microbiota intestinal | |
CN106072653A (zh) | N-乙酰氨基葡萄糖的植物蛋白饮品及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07851601 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07851601 Country of ref document: EP Kind code of ref document: A1 |